US OptionsDetailed Quotes

NEO250117P13000

Watchlist

0.00
0.000.00%

15min DelayClose Dec 24 09:30 ET

0.00High0.00Low

NeoGenomics Stock Discussion

Stock_Drift

Sep 23 18:24

$NeoGenomics (NEO.US)$

Stock_Drift

Sep 23 17:48

$NeoGenomics (NEO.US)$

Sikander KHAN

Sep 18 09:32

25 years of historical perspective of the US Federal Reserve's 'easing and tightening' of interest rates.

$NeoGenomics (NEO.US)$ 25 years of historical perspective of the US Federal Reserve's 'easing and tightening' of interest rates. In the last 25 years, the US stock market has demonstrated resilience in response to the US Federal Reserve's 'easing and tightening' of interest rates.

Another 25bp Rate Cut! What's next for the market?

Moomoo AI

Feb 29 07:27

The company's debt usage, EBIT loss, and liabilities exceeding cash and short-term receivables are worrisome. Its slow revenue growth and weak balance sheet position add to its perceived riskiness.

Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt

Moomoo Recap US

Dec 28, 2023 15:06

Columns Wall Street Today | Stocks Advance, S&P Crawling Toward Record High

RECAP
U.S. stocks traded modestly higher Thursday, pushing the S&P 500 to within just a few points of a fresh record closing high.
The $S&P 500 Index (.SPX.US)$ gained 2 points, or 0.04%, to 4,783. The $Dow Jones Industrial Average (.DJI.US)$ rose by 53 points, or 0.14%, to 37,710. The $Nasdaq Composite Index (.IXIC.US)$ fell 4 points, or 0.03%, to 15,095.
U.S. stocks opened higher as the penultimate trading session of 2023 got un...

Moomoo AI

Dec 21, 2023 01:28

The company's high P/S ratio and future revenue predictions may not sustain the positive sentiment, putting shareholder investments and potential investors at risk of overpayment.

Getting In Cheap On NeoGenomics, Inc. (NASDAQ:NEO) Is Unlikely

Moomoo AI

Nov 15, 2023 07:20

Despite a solid market capitalization, concerns arise from the EBIT level loss, liabilities against cash, and a US$50m cash burn over the last year. Slow growth rate also increases perceived risk for future performance.

NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt

Moomoo AI

Oct 11, 2023 06:01

Despite past year's lack of profitability and modest revenue growth, investor sentiment towards the future bolsters the stock. While long-term loss over five years persists, short-term return suggests a potential brighter future for NeoGenomics, Inc., albeit with identified risks.

NeoGenomics (NASDAQ:NEO) Delivers Shareholders Decent 70% Return Over 1 Year, Surging 9.2% in the Last Week Alone

MRSHINE

Jul 14, 2023 01:27

$NeoGenomics (NEO.US)$ 25 $NeoGenomics (NEO.US)$

70156082

Feb 28, 2023 11:38

$NeoGenomics (NEO.US)$ when $25+????!!!!!

No comment yet